Gujarat Kidney & Super Speciality Ltd. · NSE:GKSL
Gujarat Kidney & Super Speciality — Q2 FY27 Earnings Presentation
33 slides from Gujarat Kidney & Super Speciality's earnings presentation, Nov 4, 2026
Slide 1: Exchange filing cover letter
04/11/2026 To, To, BSE Limited National Stock Exchange of India Listing Department Limited Phiroze Jeejeebhoy Towers, Listing Department “Exchange Plaza,” 25th Floor, Dalal Street, C-1, Block – G, Bandra – Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai 400 051 Scrip Code: 544666 Scrip Code: GKSL
Slide 2: Gujarat Kidney & Super Speciality Limited Q2 FY27 Investor Presentation
Gujarat Kidney & Super Speciality Limited Q2 FY 27 Investor Presentation
Slide 3: Disclaimer
Disclaimer GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED ("Company") is contemplating the potential, subject to necessary approvals, market conditions, and other considerations, of initiating an initial public offering of its equity shares ("IPO") and has submitted the Draft Red Herring Prospectus to
Slide 4: Building a scalable, specialist-led healthcare platform
Building a scalable, specialist-led healthcare platform "Delivering quality, affordable and patient-centric care across central Gujarat." • A central Gujarat-focused hospital network combining multispeciality hospitals with in-house diagnostics and pharmacies to provide affordable, patient-centric c
Slide 5: Q2 FY27 – Strategic Highlights
Q2 FY27 – Strategic Highlights Scale-led growth, sequential margin expansion and continued inorganic build-out in Q2 FY27 ₹3,809 Lakhs ₹1,022 Lakhs ₹660 Lakhs ₹7,238 Lakhs Revenue from operations EBITDA • 26.8% margin PAT • 17.3% margin H1 FY27 revenue +11% QoQ | +195% YoY +240 bps margin QoQ +24% Q
Slide 6: Q2 & H1 FY27 Performance
Q2 & H1 FY27 Performance (Rs. in Lakhs) Revenue +195% YoY EBITDA +99% YoY PAT +129% YoY 3,809 1,022 660 512 288 1,293 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27 Revenue +157% YoY EBITDA +35% YoY PAT +44% YoY 7,238 1,859 1,192 1,375 828 2,819 H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27 INVESTOR PRESENTA
Slide 7: Profit and Loss Account – Q2 FY2026-27
Profit and Loss Account – Q2 FY2026-27 (Rs in Lakhs) Particulars (Rs. In Lakhs) Q2FY27 Q1FY27 QoQ Q2FY26 YoY Revenue from Operations 3,809 3,429 +11.1% 1,293 +194.6% Other Income 59 69 -14.8% 9 +567.5% Total Income 3,868 3,498 +10.6% 1,302 +197.1% Raw Material costs 475 434 +9.5% 130 +265.4% Gross P
Slide 8: Profit and Loss Account – H1 FY2026-27
Profit and Loss Account – H1 FY2026-27 (Rs in Lakhs) Particulars (Rs. In Lakhs) H1FY27 H1FY26 YoY Revenue from Operations 7,238 2,819 +156.8% Other Income 128 10 NM Total Income 7,366 2,829 +160.4% Expenses: Cost of medical consumables, drugs and surgical items 910 269 +237.9% Employee benefits expe
Slide 9: Balance Sheet
Balance Sheet (Rs in Lakhs) EQUITY AND LIABILITIES 30-Sep-26 31-Mar-26 31-Mar-25 Equity Share Capital 1,577 1,577 1,137 Other Equity 24,787 23,674 1,457 Total Equity 26,364 25,251 2,594 Non controlling interests 623 222 119 Non-current liabilities Borrowings 120 179 214 Lease liabilities 1,205 1,243
Slide 10: Balance Sheet
Balance Sheet (Rs in Lakhs) ASSETS 30-Sep-26 31-Mar-26 31-Mar-25 Non-current assets Property, Plant and Equipment 3,193 2,697 1,977 Right of Use Assets 1,010 1,081 411 Goodwill 10,742 9,073 713 Investments 1,200 - - Other financial assets 536 294 173 Deferred tax assets, net 271 252 68 Other non cur
Slide 11: Strategic Positioning & Highlights
Strategic Positioning & Highlights 01 02 03 LEADERSHIP AND PREFERRED HEALTHCARE MARKET POSITIONING AND MANAGEMENT DESTINATION STRATEGIC FOCUS Led by Dr. Pragnesh Yashwantsingh We have strategically focused on the Bharpoda, Promoter and Managing Director, a Our reputation, experienced management team
Slide 12: Journey of the company
Journey of the company BUILT THROUGH CLINICAL SPECIALIZATION, DISCIPLINED CAPACITY EXPANSION AND SSELECTIVE ACQUISITIONS “GOOD TO GREAT” 03 02 04 01 05 06 07 2014 2018 2019 2021 2023 2024 2025 Opened first Relocated to larger Established Gujarat Performed first Opened second hospital in Performed fi
Slide 13: Comprehensive Healthcare Services
Comprehensive Healthcare Services SPECIALITIES SUPER SPECIALITIES The picture can't be display ed. The picture can't be display ed. The picture can't be The picture can't be displayed. displayed. General Medicine General Surgery Laparoscopic Surgery Metabolic and Obesity Surgery The picture can't be
Slide 14: Pre-eminence in renal sciences, with established sub-superspecialities in urology
Pre-eminence in renal sciences, with established sub-superspecialities in urology Strong reputation in renal sciences and urology, supported by advanced sub-specialities including endourology, urologic oncology, pediatric urology, reconstructive urology, renal transplant, laparoscopic urology, and f
Slide 15: Our Integrated Business Model
Our Integrated Business Model Asset-light expansion, specialist-led capabilities and integrated care delivery BUILD THE NETWORK BUILD CLINICAL CAPABILITIES CAPTURE PATIENT JOURNEY LEASED FACILITIES OUR CORE STRENGTH OPD / CONSULTATION Patient entry and • Gujarat Kidney & Super Speciality RENAL SCIEN
Slide 16: Ability to Attract and Retain Skilled Medical Professionals
Ability to Attract and Retain Skilled Medical Professionals The picture can't be display ed. Registration of Gujarat Kidney Hospital with the Kidney Transplant Center under the Human Organs Transplantation Act, 1994. Other Staff Nurses Doctors The picture can't be display ed. Multi-disciplinary mode
Slide 17: Expanding Beyond Gujarat Through a Dubai Healthcare Platform
Expanding Beyond Gujarat Through a Dubai Healthcare Platform Entry into Dubai strengthens access to international patients and medical tourism opportunities STRATEGIC ENTRY INTO DUBAI 51% STAKE ACQUIRED Entry into the Dubai healthcare market through a majority stake in an established polyclinic (Rem
Slide 18: Asset-Light Business Model with Strong Presence in Central Gujarat
Asset-Light Business Model with Strong Presence in Central Gujarat We follow an asset-light business model, 01 operating through a mix of leased and controlled facilities across central Gujarat. Our focus on the central Gujarat region provides a distinct competitive advantage. With a presence in fou
Slide 19: Our Hospitals
Our Hospitals Hospitals Stake (%) Location Parekh Hospital 100% Ahmedabad Ashwini Medical Centre 100% Anand Surya Hospital 90% Borsad Gujarat Kidney & Superspeciality Hospital 100% Vadodara Gujarat Surgical Hospital 90% Vadodara Gujarat Multispeciality Hospital 100% Godhra Raj Palmland Hospital 51%
Slide 20: Excellence across all the operational parameters
Excellence across all the operational parameters OPD Volume & OPD Revenue (Rs. in lakhs) IPD Volume & IPD Revenue (Rs. in lakhs) OPD Volume OPD Revenue IPD Volume IPD Revenue 1,20,000 1800.00 14000 4,753 1,555.00 95,876 1600.00 13,281 6,108.00 1,00,000 12000 1400.00 78,643 10000 11,040 80,000 1,179.
Slide 21: Strategy (1/2)
Strategy (1/2) PURSUE STRATEGIC INORGANIC GROWTH IMPLEMENTATION OF INITIATIVES TO IMPROVE 01 02 OPPORTUNITIES OPERATIONAL EFFICIENCIES Actively evaluate value-accretive acquisitions and alliances that Integrated healthcare network : Streamlining operations across complement our existing operations.
Slide 22: Strategy (2/2)
Strategy (2/2) STRENGTHEN OUR EXISTING HOSPITALS AND CONTINUE TO RECRUIT AND RETAIN SKILLED 01 02 THEIR OFFERINGS AND ADD NEW CAPABILITIES HEALTHCARE PROFESSIONALS AND SPECIALTIES Focus on attracting and retaining reputed doctors, nurses, and allied healthcare Enhancing specialities across hospitals
Slide 23: Annexures
Annexures INVESTOR PRESENTATION 22
Slide 24: Industry Overview (1/3)
Industry Overview (1/3) 01 Comparative Analysis : India v/s key emerging & developed economies. Government health expenditure stood at approximately 1.9% of GDP in 2023-24, an increase from 1.28% in 2018-19. 02 The government aims to raise this to 2.5% by 2025, as outlined in the National Health Pol
Slide 25: Hospital Sector
Industry Overview (2/3) Indian Hospital Industry in India (INR Billion) Hospital Sector 5,800 6,496 4,300 The Indian hospital sector forms the core part of the healthcare industry, encompassing medical devices, clinical trials, medical tourism, 3,200 01 telemedicine, health insurance, and medical eq
Slide 26: Hospital Infrastructure in Gujarat
Industry Overview (3/3) Hospital Infrastructure Total beds in Major Government Hospitals in Gujarat 3,500 Gujarat's hospital infrastructure has evolved significantly over the years, reflecting 1,400 1,200 1,100 1,100 01 a blend of modern facilities and traditional healthcare practices. Civil Hospita
Slide 27: Key Financial Ratios
Key Financial Ratios Revenue from operations (Rs in Lakhs) EBITDA (Rs in Lakhs) PAT (Rs in Lakhs) 8201 2694 1681 4024 950 1655 171 477 195 FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25 FY26 EBITDA & PAT Margins Earnings Per Share NAV Per Equity Shares in Rs. EBITDA Margin PAT Margin 2.5 32.0 1.9 4.6 40.9%
Slide 28: Key Financial Ratios
Key Financial Ratios Trade Receivables Turnover Ratio Current Ratio 4.16 3.05 3.76 1.59 1.78 1.01 FY24 FY25 FY26 FY24 FY25 FY26 Interest Coverage Ratio Debt - Equity Ratio 24.28 20.51 11.84 0.18 0.15 0.06 FY24 FY25 FY26 FY24 FY25 FY26 INVESTOR PRESENTATION 27
Slide 29: Our Hospitals
Our Hospitals 01 02 03 04 GUJARAT KIDNEY AND GUJARAT MULTISPECIALITY GUJARAT SURGICAL RAJ PALMLAND HOSPITAL SUPERSPECIALITY HOSPITAL, HOSPITAL, GODHRA HOSPITAL IN VADODARA PVT. LTD., BHARUCH VADODARA Commenced operations in 2018. Established in 2023 with a focus on Commenced operations in 2015, Raj
Slide 30: Our Hospitals
Our Hospitals 01 02 03 APEX MULTISPECIALITY AND TRAUMA SURYA HOSPITAL & ICU, ASHWINI MEDICAL CENTRE AND CENTER, BHARUCH UNIT-1 AND UNIT-2 BORSAD ASHWINI MEDICAL STORE, ANAND Surya Hospital in Borsad commenced operations in 2021 and currently has an operational capacity of The hospital commenced oper
Slide 31: Robust Management Team and Board
Robust Management Team and Board Dr. Pragnesh Yashwantsinh Bharpoda Dr. Bhartiben Pragnesh Bharpoda Chairman and Managing Director Whole-time Director A qualified urologist and surgeon with over a decade of clinical A qualified physiotherapist with over five years of experience, experience in renal
Slide 32: Recognized for Excellence
Recognized for Excellence 2022* 2023* Registration of Gujarat Kidney Hospital with the Renewal of registration of Gujarat Kidney Hospital Kidney Transplant Center under the with Kidney Transplant Center under the Human Human Organs Transplantation Act, 1994. Organs Transplantation Act, 1994. Accredi
Slide 33: Investor Relations Contact
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara-390 020, Gujarat, India Tel No : +91 265 298 4800 Email Id : [email protected] Website : www.gujaratsuperspecialityhospital.com Investor Relatio
Gujarat Kidney and Super Speciality — Q2 FY27 Earnings Presentation on 6ix